Entering text into the input field will update the search result below

Bayer to examine the production of CureVac’s COVID-19 jab

  • Bayer (OTCPK:BAYRY) is considering expanding its agreement with CureVac (NASDAQ:CVAC) to include the production of German biopharmaceutical company’s coronavirus vaccine candidate CVnCoV, reports Welt am Sonntag.
  • In an interview with the German newspaper, the CEO of Bayer, Werner Baumann, has said that the expansion

Recommended For You

Related Stocks

SymbolLast Price% Chg
BAYRY--
Bayer Aktiengesellschaft
CVAC--
CureVac N.V.
PFE--
Pfizer Inc.
BNTX--
BioNTech SE